Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.640
-0.010 (-0.61%)
Sep 29, 2026, 2:45 PM EDT - Market open
Intelligent Bio Solutions Earnings Call Transcripts
Fiscal Year 2026
-
The discussion highlighted the company's rapid revenue growth, innovative drug screening technology, and robust FDA submission process. Plans include U.S. market entry, expanding the drug panel, and faster testing for new applications like roadside law enforcement.
-
A non-invasive drug testing device using fingertip sweat delivers results in 10 minutes and features the industry's shortest detection window, targeting workplace impairment. The business is expanding globally, shifting manufacturing to Asia for higher margins, and is preparing for FDA submission in the U.S.